Prostate cancer trials in France

In France 109 Also abroad 1481

109 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Where
Villejuif
Age
18 years and over
People
670 worldwide
Run by
AstraZeneca
See details and how to joinNCT07611110
Phase 1/2Taking people
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Where
Bordeaux, Clermont-Ferrand, Nantes, Villejuif
Age
18 years and over
People
123 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07226986 · EU 2025-521859-23-00
Phase 3Taking people
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Where
Angers, Caen Cedex 5, Montpellier Cedex 5, Paris, Poitiers, Strasbourg Cedex 2
Age
18 years and over
People
1,330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00
Phase 3Taking people
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Where
Angers, Bordeaux, Caen Cedex 5, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, Paris, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Herblain Cedex, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Suresnes, Tours Cedex 9, Vandouvre Les Nancy, Villejuif
Age
18 years and over
People
700 worldwide
Run by
AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00
Phase 3Taking people
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Where
Angers, Bayonne, Besançon, Bordeaux, Brest, Creteil Cedex, La Roche Sur Yon Cedex 9, Lyon, Nice Cedex 2, Pierre-Bénite, Reims, Villejuif
Age
18 years and over
People
1,000 worldwide
Run by
Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00
Phase 1/2Taking people
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Where
Angers, Bayonne, Bordeaux, Lille, Pierre-Bénite, Villejuif
Age
18 years and over
People
360 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06863272 · EU 2024-516036-94-00
Phase 1/2Taking people
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Where
Besancon Cedex, Bordeaux, Dijon, Paris
Age
18 years and over
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07206056 · EU 2025-521880-10-00
Phase 2Taking people
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Where
Avignon, Besancon Cedex, Bordeaux, Brest, Lille, Marseille, Saint-Grégoire, St Herblain, Toulouse Cedex 3, Toulouse Cedex 9
Age
18 years and over
People
62
Run by
Institut Bergonié
See details and how to joinNCT05346848 · EU 2023-509494-23-00
No phaseTaking people
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Where
Boulogne-Billancourt, Paris
Age
18 years and over
People
100
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121
Phase 2Taking people
Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer
Where
Bordeaux, Brest, Lille, Paris, Strasbourg Cedex, Villejuif Cedex
Age
18 years and over
People
78 worldwide
Run by
Fundacion Oncosur
See details and how to joinNCT06582628 · EU 2023-510536-37-00
Phase 1Taking people
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Where
Paris, Saint-Herblain, Villejuif
Age
18 years and over
People
180 worldwide
Run by
Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193
Phase 1/2Taking people
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Where
Lyon, Villejuif
Age
18 years and over
People
85 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06990880 · EU 2025-521581-10-00
Phase 1/2Taking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Bordeaux, Clermont-Ferrand, Lyon, Nîmes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
Age
12 years and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 1/2Taking people
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Where
Creteil Cedex, Lille, Nantes, Paris, Reims, Rennes
Age
18 years and over
People
181 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07190300 · EU 2025-521873-15-00
Phase 3Taking people
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Where
Martigues
Age
50 years to 70 years
People
1,284 worldwide
Run by
University of Alberta
See details and how to joinNCT06626022
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Bordeaux, Lyon, Suresnes
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Lyon, Marseille, Toulouse Cedex 9
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 1Taking people
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Where
Lyon, Paris, Saint-Herblain, Villejuif
Age
18 years and over
People
540 worldwide
Run by
SystImmune Inc.
See details and how to joinNCT05983432
Phase 3Taking people
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Where
Bordeaux, Bordeaux Cedex, Caen Cedex 5, Clermont Ferrand Cedex1, Le Mans Cedex 2, Lille, Lyon, Nice Cedex 2, Paris, Strasbourg Cedex 2, Suresnes, Toulouse, Vandoeuvre Les Nancy_ Cedex, Villejuif
Age
18 years and over
People
297 worldwide
Run by
Amgen Inc.
See details and how to join2025-520555-89-00 · EU 2025-520555-89-00
No phaseTaking people
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Where
Bordeaux, Marseille, Montpellier, Toulouse
Age
18 years and over
People
350
Run by
Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04104529
No phaseNot yet taking people in France
Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer
Where
Bordeaux, Marseille, Mont-de-Marsan, Paris, Quint-Fonsegrives
Age
18 years and over
People
456
Run by
GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07296042
No phaseTaking people
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
Where
Strasbourg
Age
18 years and over
People
100
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07820566
Phase 4Not yet taking people in France
Randomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
Where
Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
Age
65 years and over
People
794
Run by
Institut Gustave Roussy
See details and how to join2025-523610-83-00 · EU 2025-523610-83-00
Phase 3Taking people
[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer
Where
Lyon, Vandoeuvre Les Nancy Cedex
Age
18 years and over
People
355 worldwide
Run by
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
See details and how to join2023-504026-19-01 · EU 2023-504026-19-01